Cannabis and Bone: When the Lab and the People Disagree

Bone is not static. It is continuously rebuilt by osteoblasts that form bone and osteoclasts that resorb it, and the balance between them determines bone density. The endocannabinoid system participates in regulating that balance, which is a legitimate and somewhat unexpected research finding.

What makes this topic worth reading is that the preclinical and human evidence point in opposite directions.

The Preclinical Case

CB2 receptors are expressed on osteoblasts and osteoclasts. Their role in bone metabolism was established through genetic work: mice lacking the CB2 receptor develop age-related bone loss resembling osteoporosis. That is a strong indication the receptor matters in normal bone maintenance.

Human genetics supports the connection too. Polymorphisms in CNR2, the gene encoding CB2, have been associated with osteoporosis risk in human population studies. That is a meaningful bridge from mouse to person.

Fracture healing. A study in rats reported that CBD improved the biomechanical properties of healing femoral fractures, with the healed bone showing greater strength. The proposed mechanism involved effects on collagen crosslinking in the fracture callus.

Taken together, that is a coherent story in which cannabinoid signalling is important for bone and CBD might aid healing.

The Human Findings Go the Other Way

Studies of people who actually use cannabis heavily tend to report the opposite pattern.

Research comparing heavy cannabis users with non-users has reported lower bone mineral density, along with higher rates of fracture and lower body mass index in the cannabis group. Effects appeared more pronounced with heavier use.

This is genuinely awkward for the preclinical narrative, and it is more instructive than trying to explain it away.

Reconciling the Two

Several explanations are plausible and not mutually exclusive.

Receptor activation is not the same as receptor signalling being intact. CB2 knockout mice lack the receptor entirely. Chronic THC exposure downregulates receptors, which in effect reduces signalling. If normal CB2 signalling protects bone, chronic agonist exposure that dulls it could plausibly harm bone.

Confounding by body weight. Lower body mass is itself a risk factor for low bone density, since mechanical loading drives bone formation. Cannabis users have lower average BMI, which may account for part of the association.

Lifestyle and behavioural factors. Heavy cannabis use is associated with lower physical activity in some research, more tobacco use and dietary differences, all relevant to bone.

Injury exposure. Higher fracture rates may partly reflect more falls or higher-risk behaviour rather than weaker bone.

CBD and THC differ. Fracture healing work used CBD. Human observational work concerns cannabis use, which mostly means THC. Different compounds acting on different receptors are not interchangeable.

That last point is the one most often missed, and it means the fracture healing result and the bone density association are not necessarily in conflict at all.

Who Should Care Most

Postmenopausal women. Menopause accelerates bone loss substantially, so an additional risk factor matters more.

Older adults, particularly given the combined picture of possible lower bone density plus cannabis-related fall risk from sedation and orthostatic hypotension. Lower density and higher fall risk is the combination that produces hip fractures.

People on long-term corticosteroids or with existing osteoporosis or osteopenia.

Adolescents and young adults, who are still accumulating peak bone mass into their twenties.

What Is Not Established

No cannabinoid product is approved or recommended for osteoporosis or fracture healing. CBD should not be presented as a bone treatment, and the rat fracture study does not support that use in people.

The clinically established interventions remain what they were: adequate calcium and vitamin D, weight-bearing and resistance exercise, avoiding smoking, limiting alcohol, and bisphosphonates or other pharmacotherapy where indicated.

Practical Guidance

Do not use cannabis as a bone treatment. The evidence does not exist.

If you use heavily and have bone risk factors, mention it when bone health is assessed, since it may be relevant to interpreting a scan.

Prioritise loading. Weight-bearing exercise is the intervention with the best evidence and it also addresses the low body weight association.

Take fall prevention seriously if you are older and using cannabis, because that is where the two risks combine.

Avoid smoking, which is independently associated with lower bone density.

Bottom Line

CB2 receptors regulate bone remodelling, CB2 knockout mice lose bone, CNR2 variants are associated with human osteoporosis risk, and CBD improved fracture healing in rats. Human studies of heavy cannabis users report lower bone density and more fractures. The most likely reconciliation is that chronic THC exposure blunts protective CB2 signalling while low body weight and lifestyle factors contribute, and that CBD and THC are not the same question.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.